Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

@inproceedings{Liutkauskiene2015RetrospectiveAO,
  title={Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients},
  author={Sigita Liutkauskiene and Rasa Jan{\vc}iauskienė and Kristina Jurėnienė and Saulius Gri{\vz}as and Rasa Malonyte and Elona Juozaitytė},
  booktitle={BMC Cancer},
  year={2015}
}
Ovarian cancer is a common gynaecological malignancy still remaining a challenge to treat. The objective of this study was to evaluate the impact of platinum dose reduction and chemotherapy delays on progression free survival and overall survival in patients with stage III ovarian cancer and to analyze reasons for such chemotherapy scheme modifications. Medical records of patients with FIGO stage III ovarian cancer were reviewed. Inclusion criteria involved FIGO stage III epithelial ovarian… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS